PharmaShots Weekly | Oct 26, 2026 Edition - Join the PharmaShots Family of 20000+ Subscribers

Welcome to PharmaShots Weekly

Oct 26, 2026 Edition

PharmaShots Weekly is your Monday signal check: a fast, story-driven run-through of the deals, data, approvals, and platforms that actually shift the biopharma landscape.

AstraZeneca, Oracle Join Forces on AI Trials

METiS TechBio, Lilly Strike $1.1B LNP Deal

EQT Strikes €10.8B Deal to Acquire QIAGEN

Merck KGaA to Buy Silence Therapeutics for $1.3B

Stay Curious.

Stay informed!

Stay ahead with PharmaShots Weekly! 

Monday Briefing

Cover Story

•	Hansoh Pharma and Roche Sign ADC Collaboration Worth Over $15B

Strategic Deals & Partnerships

•	AstraZeneca and Oracle: Global AI Collaboration to Optimise Clinical Trials

•	METiS TechBio and Lilly: AI-Driven, Tissue-Specific LNP Delivery Technologies

•	AI Proteins and Astellas: Miniprotein Therapeutics Collaboration Worth Over $400M

•	Georgiamune and Menarini: Exclusive Global License for GIM-621

•	BioNTech and Gilead: Phase 3 Combination Trial of Pumitamig and Trodelvy in Triple-Negative Breast Cancer

•	Zymeworks and Roche: Global Collaboration for DLL3-Targeting Trispecific T Cell Engager ZW209

Mergers & Acquisitions

•	QIAGEN and EQT Announce Proposed €10.8B Take-Private Transaction

•	Hologic to Acquire Reveal Genomics to Expand Precision Oncology Diagnostics

PharmaShots Weekly | Oct 26, 2026 Edition

Keep reading

More issues

PharmaShots Weekly | Oct 19, 2026 Edition

PharmaShots Weekly | Oct 12, 2026 Edition